267 related articles for article (PubMed ID: 7829793)
1. Coronary artery bypass graft surgery after thrombolytic therapy in the Thrombolysis in Myocardial Infarction Trial, Phase II (TIMI II).
Gersh BJ; Chesebro JH; Braunwald E; Lambrew C; Passamani E; Solomon RE; Ross AM; Ross R; Terrin ML; Knatterud GL
J Am Coll Cardiol; 1995 Feb; 25(2):395-402. PubMed ID: 7829793
[TBL] [Abstract][Full Text] [Related]
2. Clinical and angiographic outcomes in patients with previous coronary artery bypass graft surgery treated with primary balloon angioplasty for acute myocardial infarction. Second Primary Angioplasty in Myocardial Infarction Trial (PAMI-2) Investigators.
Stone GW; Brodie BR; Griffin JJ; Grines L; Boura J; O'Neill WW; Grines CL
J Am Coll Cardiol; 2000 Mar; 35(3):605-11. PubMed ID: 10716461
[TBL] [Abstract][Full Text] [Related]
3. One-year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial. A randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-Q wave myocardial infarction.
Anderson HV; Cannon CP; Stone PH; Williams DO; McCabe CH; Knatterud GL; Thompson B; Willerson JT; Braunwald E
J Am Coll Cardiol; 1995 Dec; 26(7):1643-50. PubMed ID: 7594098
[TBL] [Abstract][Full Text] [Related]
4. Two- and three-year results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II clinical trial.
Terrin ML; Williams DO; Kleiman NS; Willerson J; Mueller HS; Desvigne-Nickens P; Forman SA; Knatterud GL; Braunwald E
J Am Coll Cardiol; 1993 Dec; 22(7):1763-72. PubMed ID: 8245326
[TBL] [Abstract][Full Text] [Related]
5. Significance of a coronary artery with thrombolysis in myocardial infarction grade 2 flow "patency" (outcome in the thrombolysis and angioplasty in myocardial infarction trials). Thrombolysis and Angioplasty in Myocardial Infarction Study Group.
Lincoff AM; Topol EJ; Califf RM; Sigmon KN; Lee KL; Ohman EM; Rosenschein U; Ellis SG
Am J Cardiol; 1995 May; 75(14):871-6. PubMed ID: 7732992
[TBL] [Abstract][Full Text] [Related]
6. Comparison of immediate invasive, delayed invasive, and conservative strategies after tissue-type plasminogen activator. Results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II-A trial.
Rogers WJ; Baim DS; Gore JM; Brown BG; Roberts R; Williams DO; Chesebro JH; Babb JD; Sheehan FH; Wackers FJ
Circulation; 1990 May; 81(5):1457-76. PubMed ID: 2110033
[TBL] [Abstract][Full Text] [Related]
7. Invasive versus conservative strategy after thrombolytic therapy for acute myocardial infarction in patients with antecedent angina. A report from Thrombolysis in Myocardial Infarction Phase II (TIMI II).
Ruocco NA; Bergelson BA; Jacobs AK; Frederick MM; Faxon DP; Ryan TJ
J Am Coll Cardiol; 1992 Dec; 20(7):1445-51. PubMed ID: 1452916
[TBL] [Abstract][Full Text] [Related]
8. [Long-term follow-up of patients with acute myocardial infarction treated with primary angioplasty or thrombolysis. Results of the MITRA trial].
Zhan R; Schiele R; Schneider S; Gitt AK; Heer T; Wienbergen H; Seidl K; Glunz HG; Hauptmann KE; Voigtländer T; Gottwik M; Senges J;
Z Kardiol; 2002 Jan; 91(1):49-57. PubMed ID: 11963207
[TBL] [Abstract][Full Text] [Related]
9. Coronary revascularization surgery after myocardial infarction: impact of bypass surgery on survival after thrombolysis. GUSTO Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.
Tardiff BE; Califf RM; Morris D; Bates E; Woodlief LH; Lee KL; Green C; Rutsch W; Betriu A; Aylward PE; Topol EJ
J Am Coll Cardiol; 1997 Feb; 29(2):240-9. PubMed ID: 9014973
[TBL] [Abstract][Full Text] [Related]
10. Thrombolytic therapy for women with myocardial infarction: is there a gender gap? Thrombolysis and Angioplasty in Myocardial Infarction Study Group.
Lincoff AM; Califf RM; Ellis SG; Sigmon KN; Lee KL; Leimberger JD; Topol EJ
J Am Coll Cardiol; 1993 Dec; 22(7):1780-7. PubMed ID: 8245328
[TBL] [Abstract][Full Text] [Related]
11. Benefit of thrombolytic therapy is sustained throughout five years and is related to TIMI perfusion grade 3 but not grade 2 flow at discharge. The European Cooperative Study Group.
Lenderink T; Simoons ML; Van Es GA; Van de Werf F; Verstraete M; Arnold AE
Circulation; 1995 Sep; 92(5):1110-6. PubMed ID: 7648654
[TBL] [Abstract][Full Text] [Related]
12. Coronary bypass surgery improves global and regional left ventricular function following thrombolytic therapy for acute myocardial infarction. TAMI Study Group.
Kereiakes DJ; Califf RM; George BS; Ellis S; Samaha J; Stack R; Martin LH; Young S; Topol EJ
Am Heart J; 1991 Aug; 122(2):390-9. PubMed ID: 1907087
[TBL] [Abstract][Full Text] [Related]
13. Implications of recurrent ischemia after reperfusion therapy in acute myocardial infarction: a comparison of thrombolytic therapy and primary angioplasty.
Stone GW; Grines CL; Browne KF; Marco J; Rothbaum D; O'Keefe J; Hartzler GO; Overlie P; Donohue B; Chelliah N
J Am Coll Cardiol; 1995 Jul; 26(1):66-72. PubMed ID: 7797777
[TBL] [Abstract][Full Text] [Related]
14. One-year outcome after therapy with tissue plasminogen activator: report from the Thrombolysis and Angioplasty in Myocardial Infarction trial.
Califf RM; Topol EJ; George BS; Kereiakes DJ; Aronson LG; Lee KL; Martin L; Candela R; Abbottsmith C; O'Neill WW
Am Heart J; 1990 Apr; 119(4):777-85. PubMed ID: 2108575
[TBL] [Abstract][Full Text] [Related]
15. Thrombolytic therapy for patients with prior percutaneous transluminal coronary angioplasty and subsequent acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries.
Labinaz M; Sketch MH; Stebbins AL; DeFranco AC; Holmes DR; Kleiman NS; Betriu A; Rutsch WR; Vahanian A; Topol EJ; Califf RM
Am J Cardiol; 1996 Dec; 78(12):1338-44. PubMed ID: 8970403
[TBL] [Abstract][Full Text] [Related]
16. Ten-year outcomes of patients randomized to surgery, angioplasty, or medical treatment for stable multivessel coronary disease: effect of age in the Medicine, Angioplasty, or Surgery Study II trial.
Rezende PC; Hueb W; Garzillo CL; Lima EG; Hueb AC; Ramires JA; Kalil Filho R
J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1105-12. PubMed ID: 22944095
[TBL] [Abstract][Full Text] [Related]
17. Tissue-type plasminogen activator therapy versus primary coronary angioplasty: impact on myocardial tissue perfusion and regional function 1 month after uncomplicated myocardial infarction.
Agati L; Voci P; Hickle P; Vizza DC; Autore C; Fedele F; Feinstein SB; Dagianti A
J Am Coll Cardiol; 1998 Feb; 31(2):338-43. PubMed ID: 9462577
[TBL] [Abstract][Full Text] [Related]
18. Thrombolysis in Myocardial Infarction (TIMI) phase II trial: outcome comparison of a "conservative strategy" in community versus tertiary hospitals. The TIMI Research Group.
Feit F; Mueller HS; Braunwald E; Ross R; Hodges M; Herman MV; Knatterud GL
J Am Coll Cardiol; 1990 Dec; 16(7):1529-34. PubMed ID: 2123901
[TBL] [Abstract][Full Text] [Related]
19. Outcome of different reperfusion strategies in patients with former contraindications to thrombolytic therapy: a comparison of primary angioplasty and tissue plasminogen activator. Primary Angioplasty in Myocardial Infarction (PAMI) Investigators.
Stone GW; Grines CL; Browne KF; Marco J; Rothbaum D; O'Keefe JH; Hartzler GO; Overlie P; Donohue B; Chelliah N; Vlietstra R; Puchrowicz-Ochocki S; O'Neill WW
Cathet Cardiovasc Diagn; 1996 Dec; 39(4):333-9. PubMed ID: 8958418
[TBL] [Abstract][Full Text] [Related]
20. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group.
Grines CL; Browne KF; Marco J; Rothbaum D; Stone GW; O'Keefe J; Overlie P; Donohue B; Chelliah N; Timmis GC
N Engl J Med; 1993 Mar; 328(10):673-9. PubMed ID: 8433725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
